Detecting Unrecognized Cognitive Impairment and Dementias Using Clinical Health Systems Bioinformatics and Electronic Health Records from a National Population

Ara S Khachaturian,Michal S Beeri,Gang Li,Ramit Ravona‐Springer

DOI: https://doi.org/10.1002/alz.078340

2023-01-01

Alzheimer s & Dementia

Abstract:AbstractGlobally there are upwards of 35 million people living with dementia and other cognitive impairments, with total annual costs of approximately US$ 1 trillion by 2025. Yet, this estimate does not consider the impact due to the lack of specialized personnel and health care infrastructure to provide timely access for dementia diagnosis, treatment, and care. These factors are complicated by the lack of valid and equitable means for detecting signs of impending cognitive impairment or dementia. Also, these same symptoms are not easily recognized by many primary care physicians who do not make referrals to specialists. These negative dynamics on access to quality brain healthcare may impact under‐represented, underserved, and vulnerable populations at disproportionately greater levels. Although more AD/ADRD interventions will be approved, this will not assure equal market access. There is an immediate need to provide accurate, affordable, appropriate, and equitable clinical care profiles. One approach is to develop digital tools to access electronic health record (EHR) data. Yet, generic EHR data on dementia status are limited to people who have received a formal diagnosis. Worse, in the community setting, most people enduring cognitive impairment or living with dementia will not receive generally a timely diagnosis to support useful clinical care decision‐making. Fortunately, several international health data reservoirs exist that integrate routine EHR data with dementia research‐driven cohort studies with affiliated biobanks, including Sheba Medical Center (SMC) with its ongoing ‐omics and neuroimaging research. As Israel has socialized medicine, and all residents have healthcare provided through the Israeli National Health Insurance law, the Sheba data offers a unique opportunity to develop valid, reliable, and transportable EHR derived assessment tools for cognitive impairment and dementia. The project in collaboration with SMC and Maccabi Healthcare Service—one of four national Israeli medical service providers—demonstrates the advanced capabilities to use electronic medical records linked with a national network of primary care physicians, and the ability to conduct deep‐source data mining in the absence of a clinical diagnosis of cognitive impairment or dementia. The project reports the performance characteristics (i.e., sensitivity and specificity) of assessment tools to detect cognitive impairment or dementia.